Matthew Havrda

Studying the brain at Dartmouth

[MSBDartmouth @MsbDartmouth]

Molecular & Systems Biology at the Geisel School of Medicine at Dartmouth is excited to recruit an Assistant Professor to our department. Find information on the breadth of our search and our commitment to faculty diversity at https://t.co/9vvKi0k7zN @GeiselMed @Dartmouth

[Francesca Gilli @francesca_gilli]

New paper alert! Awesome work from PhD student @SeqWithSteve with @lsalas_epigenet and @MatthewHavrda. Way to go Steve! @DartmouthNeuro @DartmouthHealth @GeiselMed

[David Standaert MD, PhD @DavidStandaert]

https://t.co/JnTq6x3nIO

[Parkinson's Foundation @ParkinsonDotOrg]

Help us change the #FutureOfPD 🤝 Sign up for a #MovingDayWalk near you today and start raising funds and awareness for Parkinson’s disease: https://t.co/s8EVgdU1Vn

[The Kettenbach Lab @KettenbachLab]

⁦Awesome presentation on the role of PP2A in Wnt signaling by ⁦⁦@NawatBunnag⁩ at Europhosphatases 2023 in Copenhagen ⁦@MCBDartmouth⁩

[Alicia Barber Minteer, PhD @aliciajbarber]

I am featured in this article commenting on how #ApoE4 genotype status and sex seem to impact the benefit and risk of #Leqembi treatment.

The future of treating #Alzheimers disease is developing a personalized medicine approach to care - incorporating factors like sex, genetics, and more, into one’s treatment regimen. Anti-amyloid antibody drugs are a start to this future becoming a reality. While they are certainly not a cure for Alzheimer’s disease, they can be thought of as an important addition to a tool belt, that will hopefully one day be full of a number of different drugs, that will work in tandem, in unique combinations, to fight Alzheimer’s disease. A one size fits all approach can and should not be the goal.

Great explanatory article by @AmandaKrupa !

[Parkinson's Foundation Research @PFResearchTeam]

📢 And our final kudos to @bdemiranda, 2023 Stanley Fahn Awardee (and former Postdoc Awardee!) who will be looking at how environmental exposures accelerate senescence and influence #Parkinsons neurodegeneration @UABNews.

@ParkinsonDotOrg

[Parkinson's Foundation Research @PFResearchTeam]

📢 Congratulations are in order for 2023 Postdoctoral Fellowship Awardee @tahneesaunders 🇦🇺, who will be restraining mitochondrial damage-induced inflammation to treat #Parkinsons disease @WEHI_research

@ParkinsonDotOrg

[Parkinson's Foundation @ParkinsonDotOrg]

Can you help us #ReachFurther? The Parkinson’s Foundation Reach Further campaign will invest an additional $30 million to accelerate progress on Parkinson’s disease research, improve care and increase access to quality-of-life programs. 💙 🩺

Learn more: https://t.co/KYcjSE4MxG

[Jefferson Health Neuroscience @NeuroatJeff]

Communication is multi-modal, including both speech & gesture. Many patients with left hemisphere stroke have impairments in both domains. Research in the Cognition & Action Lab at @MossResearch is helping us understand how gesture impairment (limb apraxia) impacts communication.

[Matthew Havrda @MatthewHavrda]

Rising stars on display @dartmouth Wetterhahn undergraduate advising and research symposium.

[Parkinson's Foundation @ParkinsonDotOrg]

Did you know that the Parkinson's Foundation has resources specifically for Veterans with Parkinson's disease? For Military Appreciation Month, check out our YouTube playlist for Veterans with PD and their care partners: https://t.co/76ogyX0Cqy

[Matthew Havrda @MatthewHavrda]

Sunny day in Philadelphia talking #Parkinson and meeting with great scientists @NeuroatJeff @Jeff_PD_center

[Matthew Havrda @MatthewHavrda]

@lvolpic @MichaelOkun Sample size is pretty solid. If nothing else study highlights the power of VA data resources. Lots of info locked in that DOS database!

[Maxime Rousseaux @maximewc]

🚨Looking for a Research Assistant to join our vibrant team @uOttawaBMRI @OISB_IBSO @CNMDOttawa @uOttawaMed. Please spread the word! 👩‍🔬👨‍🔬🥼🧪

https://t.co/spgYzrRHCZ

[Parkinson's Foundation @ParkinsonDotOrg]

A recent study adds promising new data to bolster support for a test that may allow Parkinson’s to be diagnosed before symptoms appear and may help inform Parkinson’s clinical trials.

🩺 Learn more on our website: https://t.co/VyFXwnH7Nu

[Matthew Havrda @MatthewHavrda]

Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune | Movement Disorders | JAMA Neurology | JAMA Network https://t.co/WEwn3RAoCz

[Matthew Havrda @MatthewHavrda]

Great week of science and fun #Parkinsons @GordonConf⁩. Echoing a big thanks to ⁦@MaluTansey⁩ and ⁦@NelsonLabUCSF⁩ for an unforgettable meeting!

[MSBDartmouth @MsbDartmouth]

The Halpern Lab is recruiting ! Please share ! Follow the link for a full description of this research technician opportunity and instructions on how to apply. https://t.co/Jt2bSY8pW9
@dartmouth @GeiselMed @marnieeh @MCBDartmouth @DartmouthNeuro @QBSdartmouth @DartGRAD

[Matthew Havrda @MatthewHavrda]

@MaluTansey Free skiing for us!